InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Browse the full record of transactions filed by Bazemore Todd, Chief Operating Officer. Director active across 1 companies, notably Kala Pharmaceuticals, Inc.. In total, 7 disclosures have been published. Total volume traded: €76k. The latest transaction was disclosed on 27 June 2022 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations7 total
€1,0813,092 shares@ €0.34970.0070% mcap1.4% of flow
Common Stock
SEC:0001415889-22-007060:0·
€3,9733,454 shares@ €1.150210.6% of flow
Common Stock
SEC:0001415889-22-000403·
€3,9733,454 shares@ €1.15020.026% mcap5.2% of flow
Common Stock
SEC:0001415889-22-000403:0·
€19,46812,544 shares@ €1.55251.9% of flow
Common Stock
SEC:0001415889-21-005011·
€19,46812,544 shares@ €1.5520.13% mcap25.6% of flow
Common Stock
SEC:0001415889-21-005011:0·
€14,0802,911 shares@ €4.83737.5% of flow
Common Stock
SEC:0001415889-21-003257·
€14,0802,911 shares@ €4.8370.091% mcap18.5% of flow
Common Stock
SEC:0001415889-21-003257:0·
7 of 7 declarations
About Bazemore Todd
Todd Bazemore is the Chief Operating Officer at Kala Pharmaceuticals, Inc. He is responsible for managing the company's operations, contributing to overall efficiency and performance. His role is essential for the operational strategy of Kala Pharmaceuticals, Inc.
